世界のミダゾラム市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20SP09457)
◆英語タイトル:Global Midazolam Market 2020 by Company, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20SP09457
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年9月23日(※2024年版があります。お問い合わせください。)
◆ページ数:106
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、ミダゾラムの世界市場を広く調査・分析し、今後の市場展望をまとめております。ミダゾラムの種類別市場規模(錠剤、注射剤)、用途別市場規模(麻酔、不眠症、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Roche、Zhejiang Jiuxu Pharmaceutical、West-Ward Pharmaceuticals Corp、Pfizer、Nichi-Iko、Apotex Corporation、Humanwell Healthcare、Akorn、Alvogen、Nhwa Pharmaceutical
・地域別グローバル市場分析 2015年-2020年
・ミダゾラムの北米市場(アメリカ、カナダ、メキシコ)
・ミダゾラムのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・ミダゾラムのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・ミダゾラムの南米市場(ブラジル、アルゼンチン)
・ミダゾラムの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:錠剤、注射剤
・用途別分析:麻酔、不眠症、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論
【レポートの概要】

Market Overview
The Midazolam market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Midazolam sales will be xx in 2020 from Midazolam million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Midazolam market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Midazolam industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Midazolam and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Midazolam market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Midazolam market has been segmented into:
Tablets
Injection

By Application, Midazolam has been segmented into:
Anesthesia
Insomnia
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Midazolam market presented in the report. This section sheds light on the sales growth of different regional and country-level Midazolam markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Midazolam market.

The report offers in-depth assessment of the growth and other aspects of the Midazolam market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Midazolam Market Share Analysis
Midazolam competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Midazolam sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Midazolam sales, revenue and market share for each player covered in this report.

The major players covered in Midazolam are:
Roche
Zhejiang Jiuxu Pharmaceutical
West-Ward Pharmaceuticals Corp
Pfizer
Nichi-Iko
Apotex Corporation
Humanwell Healthcare
Akorn
Alvogen
Nhwa Pharmaceutical
Among other players domestic and global, Midazolam market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

【レポートの目次】

1 Midazolam Market Overview
1.1 Product Overview and Scope of Midazolam
1.2 Classification of Midazolam by Type
1.2.1 Global Midazolam Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Midazolam Revenue Market Share by Type in 2019
1.2.3 Tablets
1.2.4 Injection
1.3 Global Midazolam Market by Application
1.3.1 Overview: Global Midazolam Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Anesthesia
1.3.3 Insomnia
1.3.4 Other
1.4 Global Midazolam Market by Regions
1.4.1 Global Midazolam Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Midazolam (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Midazolam Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Midazolam Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Midazolam Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Midazolam Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Midazolam Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Midazolam Industry Impact
1.5.1 COVID-19 Potential Implications for the Midazolam
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Midazolam
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Midazolam Revenue, Gross Margin and Market Share (2018-2019)
2.2 Zhejiang Jiuxu Pharmaceutical
2.2.1 Zhejiang Jiuxu Pharmaceutical Details
2.2.2 Zhejiang Jiuxu Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Zhejiang Jiuxu Pharmaceutical SWOT Analysis
2.2.4 Zhejiang Jiuxu Pharmaceutical Product and Services
2.2.5 Zhejiang Jiuxu Pharmaceutical Midazolam Revenue, Gross Margin and Market Share (2018-2019)
2.3 West-Ward Pharmaceuticals Corp
2.3.1 West-Ward Pharmaceuticals Corp Details
2.3.2 West-Ward Pharmaceuticals Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 West-Ward Pharmaceuticals Corp SWOT Analysis
2.3.4 West-Ward Pharmaceuticals Corp Product and Services
2.3.5 West-Ward Pharmaceuticals Corp Midazolam Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Midazolam Revenue, Gross Margin and Market Share (2018-2019)
2.5 Nichi-Iko
2.5.1 Nichi-Iko Details
2.5.2 Nichi-Iko Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Nichi-Iko SWOT Analysis
2.5.4 Nichi-Iko Product and Services
2.5.5 Nichi-Iko Midazolam Revenue, Gross Margin and Market Share (2018-2019)
2.6 Apotex Corporation
2.6.1 Apotex Corporation Details
2.6.2 Apotex Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Apotex Corporation SWOT Analysis
2.6.4 Apotex Corporation Product and Services
2.6.5 Apotex Corporation Midazolam Revenue, Gross Margin and Market Share (2018-2019)
2.7 Humanwell Healthcare
2.7.1 Humanwell Healthcare Details
2.7.2 Humanwell Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Humanwell Healthcare SWOT Analysis
2.7.4 Humanwell Healthcare Product and Services
2.7.5 Humanwell Healthcare Midazolam Revenue, Gross Margin and Market Share (2018-2019)
2.8 Akorn
2.8.1 Akorn Details
2.8.2 Akorn Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Akorn SWOT Analysis
2.8.4 Akorn Product and Services
2.8.5 Akorn Midazolam Revenue, Gross Margin and Market Share (2018-2019)
2.9 Alvogen
2.9.1 Alvogen Details
2.9.2 Alvogen Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Alvogen SWOT Analysis
2.9.4 Alvogen Product and Services
2.9.5 Alvogen Midazolam Revenue, Gross Margin and Market Share (2018-2019)
2.10 Nhwa Pharmaceutical
2.10.1 Nhwa Pharmaceutical Details
2.10.2 Nhwa Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Nhwa Pharmaceutical SWOT Analysis
2.10.4 Nhwa Pharmaceutical Product and Services
2.10.5 Nhwa Pharmaceutical Midazolam Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Midazolam Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Midazolam Players Market Share
3.2.2 Top 10 Midazolam Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Midazolam Revenue and Market Share by Regions
4.2 North America Midazolam Revenue and Growth Rate (2015-2020)
4.3 Europe Midazolam Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Midazolam Revenue and Growth Rate (2015-2020)
4.5 South America Midazolam Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Midazolam Revenue and Growth Rate (2015-2020)
5 North America Midazolam Revenue by Countries
5.1 North America Midazolam Revenue by Countries (2015-2020)
5.2 USA Midazolam Revenue and Growth Rate (2015-2020)
5.3 Canada Midazolam Revenue and Growth Rate (2015-2020)
5.4 Mexico Midazolam Revenue and Growth Rate (2015-2020)
6 Europe Midazolam Revenue by Countries
6.1 Europe Midazolam Revenue by Countries (2015-2020)
6.2 Germany Midazolam Revenue and Growth Rate (2015-2020)
6.3 UK Midazolam Revenue and Growth Rate (2015-2020)
6.4 France Midazolam Revenue and Growth Rate (2015-2020)
6.5 Russia Midazolam Revenue and Growth Rate (2015-2020)
6.6 Italy Midazolam Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Midazolam Revenue by Countries
7.1 Asia-Pacific Midazolam Revenue by Countries (2015-2020)
7.2 China Midazolam Revenue and Growth Rate (2015-2020)
7.3 Japan Midazolam Revenue and Growth Rate (2015-2020)
7.4 Korea Midazolam Revenue and Growth Rate (2015-2020)
7.5 India Midazolam Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Midazolam Revenue and Growth Rate (2015-2020)
8 South America Midazolam Revenue by Countries
8.1 South America Midazolam Revenue by Countries (2015-2020)
8.2 Brazil Midazolam Revenue and Growth Rate (2015-2020)
8.3 Argentina Midazolam Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Midazolam by Countries
9.1 Middle East & Africa Midazolam Revenue by Countries (2015-2020)
9.2 Saudi Arabia Midazolam Revenue and Growth Rate (2015-2020)
9.3 UAE Midazolam Revenue and Growth Rate (2015-2020)
9.4 Egypt Midazolam Revenue and Growth Rate (2015-2020)
9.5 South Africa Midazolam Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Midazolam Revenue and Market Share by Type (2015-2020)
10.2 Global Midazolam Market Forecast by Type (2019-2024)
10.3 Tablets Revenue Growth Rate (2015-2025)
10.4 Injection Revenue Growth Rate (2015-2025)
11 Global Midazolam Market Segment by Application
11.1 Global Midazolam Revenue Market Share by Application (2015-2020)
11.2 Midazolam Market Forecast by Application (2019-2024)
11.3 Anesthesia Revenue Growth (2015-2020)
11.4 Insomnia Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Midazolam Market Size Forecast (2021-2025)
12.1 Global Midazolam Market Size Forecast (2021-2025)
12.2 Global Midazolam Market Forecast by Regions (2021-2025)
12.3 North America Midazolam Revenue Market Forecast (2021-2025)
12.4 Europe Midazolam Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Midazolam Revenue Market Forecast (2021-2025)
12.6 South America Midazolam Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Midazolam Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

...

【掲載企業】

Roche、Zhejiang Jiuxu Pharmaceutical、West-Ward Pharmaceuticals Corp、Pfizer、Nichi-Iko、Apotex Corporation、Humanwell Healthcare、Akorn、Alvogen、Nhwa Pharmaceutical

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のミダゾラム市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global Midazolam Market 2020 by Company, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。